In terms of market performance, Surmodics, Inc had a somewhat inconsistent run in. The highest value for the stock in the past year was $41.88 on 07/26/24, while the lowest value was $26.00 on 04/30/25.
52-week price history of SRDX Stock
Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Surmodics, Inc’s current trading price is -14.04% away from its 52-week high, while its distance from the 52-week low is 38.46%. The stock’s price range for this period has remained between $26.00 and $41.88. The Healthcare sector company’s shares managed to surpass a trading volume of around 0.5 million for the day, which was noticeably higher compared to the shares’ average daily volume of 82600.0 over the last three months.
Financial Performance and Market Capitalization
Surmodics, Inc (SRDX) has experienced a quarterly rise of 22.45% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 514.77M and boasts a workforce of 389 employees.
Analysts’ Ratings For Surmodics, Inc
As of right now, 0 analyst is rating Surmodics, Inc as a BUY, 0 of the polled analysts branded the stock as an OVERWEIGHT, 2 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 29.37, with a change in price of +5.05. Similarly, Surmodics, Inc recorded 107,843 in trading volume during the last 100 days, posting a change of +16.32%.
SRDX Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for SRDX stands at 0.30. Similarly, the long-term debt-to-equity ratio is also 0.29.
SRDX Stock Stochastic Average
As of today, the raw stochastic average of Surmodics, Inc over the last 50 days is at 98.34%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 98.26%. Further, the company’s Stochastic %K and %D values for the last 20 days were 89.84% and 90.18%, respectively.
SRDX Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. This year’s metric has recorded a Price decrease of -13.88%. However, over the past six months, we’ve seen a stronger performance of -4.00%. The price of SRDX fallen by 24.52% over the last 30 days. And in the last five days, it has surged by 19.17%.
